Barriers to generating PDX models of HPV-related head and neck cancer

被引:30
|
作者
Facompre, Nicole D. [1 ]
Sahu, Varun [1 ]
Montone, Kathleen T. [1 ,2 ]
Harmeyer, Kayla M. [1 ]
Nakagawa, Hiroshi [3 ]
Rustgi, Anil K. [3 ]
Weinstein, Gregory S. [1 ]
Gimotty, Phyllis A. [4 ]
Basu, Devraj [1 ,5 ,6 ]
机构
[1] Univ Penn, Dept Otorhinolaryngol Head & Neck Surg, 3400 Spruce St,5 Ravdin Silverstein, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Pathol, Philadelphia, PA 19104 USA
[3] Univ Penn, Dept Med, Philadelphia, PA 19104 USA
[4] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA
[5] Philadelphia VA Med Ctr, Philadelphia, PA USA
[6] Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA
来源
LARYNGOSCOPE | 2017年 / 127卷 / 12期
关键词
Patient-derived xenograft; HPV; head and neck cancer; preclinical model; SQUAMOUS-CELL CARCINOMA; PAPILLOMAVIRUS-POSITIVE HEAD; PATIENT-DERIVED XENOGRAFTS; HUMAN-MALIGNANT TUMOR; OROPHARYNGEAL CANCER; LUNG-CANCER; NUDE-MICE; IMMUNODEFICIENT MICE; EPITHELIAL-CELLS; ROCK INHIBITOR;
D O I
10.1002/lary.26679
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objectives/HypothesisDelineate factors impacting the creation and use of patient-derived xenografts (PDXs) of human papilloma virus-related (HPV+) head and neck squamous cell carcinomas (HNSCCs). Study DesignLaboratory-based translational study. MethodsFifty-one surgically resected HNSCCs, including 31 HPV+cancers, were implanted into NOD/SCID/IL-2R(-/-) (NSG) mice using standardized methodology. Clinical and pathologic factors were tested for association with engraftment. The gross, histologic, and molecular features of established HPV+PDXs were analyzed in comparison to their tumors of origin. ResultsNegative HPV status and perineural invasion (PNI) were independent, additive factors associated with increased PDX formation. Epstein-Barr virus-positive (EBV+) human large B-cell lymphomas grew from 32% of HPV+HNSCC cases that failed to engraft. Successfully established HPV+PDXs retained basaloid histology and often developed cystic growth patterns typical of HPV+nodal metastases. They also maintained elevated p16(INK4A) levels and expression of E6/E7 viral oncogene transcripts. ConclusionReduced engraftment by HPV+tumors lacking PNI likely results in selection biases in HNSCC PDX models. Formation of EBV+lymphomas in NSG mice further reduces the generation of HPV+models and must be ruled out before long-term use of PDXs. Nevertheless, the retention of distinctive pathologic traits and viral oncogene expression by HPV+PDXs provides a viable in vivo platform for basic and translational studies as well as a resource for generating advanced in vitro models. Level of EvidenceNA. Laryngoscope, 127:2777-2783, 2017
引用
收藏
页码:2777 / 2783
页数:7
相关论文
共 50 条
  • [41] The role of miRNAs in human papilloma virus (HPV)-associated cancers: bridging between HPV-related head and neck cancer and cervical cancer
    Lajer, C. B.
    Garns, E.
    Friis-Hansen, L.
    Norrild, B.
    Therkildsen, M. H.
    Glud, M.
    Rossing, M.
    Lajer, H.
    Svane, D.
    Skotte, L.
    Specht, L.
    Buchwald, C.
    Nielsen, F. C.
    BRITISH JOURNAL OF CANCER, 2012, 106 (09) : 1526 - 1534
  • [42] Comprehensive analysis of mitophagy in HPV-related head and neck squamous cell carcinoma
    Li Yanan
    Liang Hui
    Cheng Zhuo
    Ding Longqing
    Sun Ran
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [43] Spatial transcriptomic analysis of HPV-related and HPV-unrelated head and neck squamous cell carcinoma
    Barrett, Thomas F.
    Simkin, Dor
    Greenwald, Alissa R.
    Parikh, Anuraag
    Gay, Hiram
    Apicelli, Anthony
    Adkins, Douglas
    Thorstad, Wade
    Rich, Jason T.
    Paniello, Randal C.
    Zolkind, Paul
    Pipkorn, Patrik
    Jackson, Ryan S.
    Chernock, Rebecca
    Tirosh, Itay
    Puram, Sidharth V.
    CLINICAL CANCER RESEARCH, 2023, 29 (18)
  • [44] Erratum: The role of miRNAs in human papilloma virus (HPV)-associated cancers: bridging between HPV-related head and neck cancer and cervical cancer
    C B Lajer
    E Garnæs
    L Friis-Hansen
    B Norrild
    M H Therkildsen
    M Glud
    M Rossing
    H Lajer
    D Svane
    L Skotte
    L Specht
    C Buchwald
    F C Nielsen
    British Journal of Cancer, 2017, 117 : e2 - e2
  • [45] Impact of HPV-Related Head and Neck Cancer in Clinical Trials: Opportunity to Translate Scientific Insight into Personalized Care
    Chung, Christine H.
    Schwartz, David L.
    OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, 2012, 45 (04) : 795 - +
  • [46] Excess HPV-related head and neck cancer in the world trade center health program general responder cohort
    Graber, Judith M.
    Harris, Gerald
    Black, Kathleen
    Lucchini, Roberto G.
    Giuliano, Anna R.
    Dasaro, Christopher R.
    Shapiro, Moshe
    Steinberg, Michael B.
    Crane, Michael A.
    Moline, Jacqueline M.
    Harrison, Denise J.
    Luft, Benjamin J.
    Todd, Andrew C.
    Udasin, Iris G.
    INTERNATIONAL JOURNAL OF CANCER, 2019, 145 (06) : 1504 - 1509
  • [47] The evolution of the epidemiological landscape of head and neck cancer in Italy: Is there evidence for an increase in the incidence of potentially HPV-related carcinomas?
    Boscolo-Rizzo, Paolo
    Zorzi, Manuel
    Del Mistro, Annarosa
    Da Mosto, Maria Cristina
    Tirelli, Giancarlo
    Buzzoni, Carlotta
    Rugge, Massimo
    Polesel, Jerry
    Guzzinati, Stefano
    PLOS ONE, 2018, 13 (02):
  • [48] A novel ΔNp63-dependent immune mechanism improves prognosis of HPV-related head and neck cancer
    Mourtada, Jana
    Lony, Christelle
    Nicol, Anais
    De Azevedo, Justine
    Bour, Cyril
    Macabre, Christine
    Roncarati, Patrick
    Ledrappier, Sonia
    Schultz, Philippe
    Borel, Christian
    Burgy, Mickael
    Wasylyk, Bohdan
    Mellitzer, Georg
    Herfs, Michael
    Gaiddon, Christian
    Jung, Alain C.
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [49] HPV-Related Prognostic Signature Predicts Survival in Head and Neck Squamous Cell Carcinoma
    Zhao, Hongyu
    Wang, Fengxu
    Wang, Xuehai
    Zhao, Xinyuan
    Ji, Jinfeng
    JOURNAL OF ONCOLOGY, 2022, 2022
  • [50] Biology of Human Papillomavirus Infection and Immune Therapy for HPV-Related Head and Neck Cancers
    Best, Simon R.
    Niparko, Kevin J.
    Pai, Sara I.
    OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, 2012, 45 (04) : 807 - +